Perspective article

Sort by: Newest first Oldest first A-Z Z-A

  • Pill blister packs

    Antidepressants in the treatment of major depression: a changing landscape for clinical decision making Subscription

    2 APR 2019 By John Donoghue

    With publication of the update to the National Institute of Health and Care Excellence depression guideline postponed until late 2019, this article aims to examine the findings of the Cipriani et al. meta-analysis in the wider context of the management of depression in the UK.

  • A person researching suicide on the mind.org website

    What could UK pharmacy teams learn about suicide prevention from North America? Subscription

    5 MAR 2019 By Hayley Gorton

    From the perspective of their clinical and holistic role, and restriction of access to means, there are opportunities to involve pharmacy teams in suicide prevention. This article examines the published evidence-base and the success of ongoing programmes and initiatives in the United States and Canada to produce a set of recommendations for the benefit of UK practice on the opportunities community pharmacy teams have to raise awareness and help prevent suicide and self-harm.

  • Members of the Northumbria Vanguard team

    Impact of an integrated pharmacy service on hospital admission costs Subscription

    8 MAY 2018 By Wasim Baqir, Paul Paes, Andrea Stoker, Emma Morris, Rachel McWhir, Helen Ridley, Scott Barrett, Richard Copeland, Robin Hudson, Steven Barrett, Jacqueline Ballantyne, David Campbell

    Northumberland was chosen as one of the national vanguard sites in early 2015, in response to the Five year forward view initiative. This article describes the evolution of the integrated pharmacy service, which now operates across organisational boundaries and in collaboration with other healthcare professionals, as well as the improvements in patient care, harm reduction and increased efficiencies achieved using a sustainable model of care.

  • Adult woman with Down's Syndrome

    The implications of the Montgomery judgment on pharmacy practice and patients with learning disability Subscription

    28 NOV 2017 By Danielle Adams, Claudia Carr

    The judgment in Montgomery v Lanarkshire (Scotland) 2015 introduced a new definition of informed consent which has implications for all healthcare professionals. This article focuses specifically on the implications for pharmacy practice and patients with learning disability. During consultations, both pharmacist prescribers and non-prescribing pharmacists must adhere to the provisions of the judgment to ensure patients provide informed consent. Particular issues arise where patients ...

  • Woman breathes into a spirometre to check for COPD

    Demonstrating the patient benefit and value for the NHS of community pharmacy: insight from the Community Pharmacy Future model Subscription

    Comments (1)

    In the face of funding and efficiency cuts to community pharmacy, the role of the sector is coming under increasing pressure. The importance of outcomes evidence (particularly health economic evidence) is being brought sharply into focus. The profession must come together to produce the evidence needed to justify the services provided by community pharmacy and to support its future development. This article uses the Community Pharmacy Future (CPF) project, and the services developed ...

  • Rows of over-the-counter (OTC) cough medicine

    A new way to look at acute cough in the pharmacy Subscription

    31 MAR 2017 By Alyn H Morice
    Comments (3)

    Cough is the most common symptom for which people seek medical advice, and patients with cough frequently present to community pharmacy. Cough can be either acute or chronic. Acute cough, defined as being of less than three weeks’ duration, is often caused by viral respiratory tract infection and is probably one of the most common reasons for accessing healthcare in the community. For these infections, no antiviral treatment exists and antibiotics have been shown to be ineffective in ...

  • Teenager gets an HPV vaccine injection

    The impact of the human papillomavirus vaccine in Scotland: a changing landscape Subscription

    In the UK, cervical cancer is the second most common cancer in women aged under 35 years. Human papillomavirus (HPV) types 16 and 18 (both high risk) are necessary precipitants in at least 70% of cervical cancers but may contribute to more than 80% of cervical cancers in Scotland. Both the prophylactic bivalent (Cervarix; GlaxoSmithKline) and quadrivalent (Gardasil; Merck) vaccines prevent infection with HPV types 16 and 18, and have been shown to induce avid and sustained neutralising ...

  • NHS pharmacist discusses patient care with a nurse on a ward

    Examining the emerging roles for pharmacists as part of the urgent, acute and emergency care workforce Subscription

    In the future urgent, acute and emergency medicine clinical workforce, new models of care and care delivery need to be developed, in order to maintain and enhance standards of safe and accessible patient care. A departure from traditional (doctor-led) approaches to workforce planning, and an understanding of scope and governance surrounding emerging clinical roles is necessary to develop a sustainable, multi-skilled workforce across primary, community and secondary care. Today’s ...

  • Scanning electron micrograph (SEM) of a lymphocyte with HIV cluster

    Pre-exposure prophylaxis should be a key component of a comprehensive HIV prevention package fully funded on the NHS Subscription

    29 NOV 2016 By Collette Brydon

    Pre-exposure prophylaxis (PrEP) is the medication taken by HIV-negative individuals to reduce their risk of contracting HIV infection. The large evidence base for the use of PrEP has been reviewed and recommended by the World Health Organization (WHO), a specialised agency of the United Nations that is concerned with international public health, the Joint United Nations Programme on HIV and AIDS (UNAIDS) and the National Institute for Health and Care Excellence (NICE), England’s health ...

  • 3D MRI scan of a breast with breast cancer

    Improving long-term adjuvant anti-oestrogenic therapy for breast cancer Subscription

    Long-term (five years) adjuvant tamoxifen treatment for oestrogen receptor-positive, or ER-positive, breast cancer post-surgery is recognised as a major advance in healthcare. Clinical trials comparing standard and extended tamoxifen therapy found a major decrease in mortality occurred in the ten years following a decade of adjuvant therapy. Studies in premenopausal breast cancer patients showed that ovarian function suppression (OFS) an aromatase inhibitor (AI), ...

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

fashioncarpet.com.ua

колесо для тележки

складские стеллажи